Globally, the physical and financial health of humans is in freefall as the pandemic SARS-CoV-2 (COVID-19) has filled hospitals with patients and forced businesses to shut down. Furthermore, if people are quarantined for too long (due to the non-availability of a vaccine or drug), the damage it will cause to the economy may be far worse than the disease itself!
It’s a relief to know that vaccine researchers are working round the clock to develop a vaccine. The hope for quick relief, however, depends on the collaboration and sharing of vaccine reports with the help of reporting software like Windward among researchers and scientists (this is evidenced by the fact that vaccine research was only made possible when Chinese scientists shared the genetic code of the virus).
Windward can accelerate the development of the vaccine by creating swift and accurate pre-clinical and clinical trial vaccine reports.
Moreover, there’s a challenge, researchers may want to keep certain details of their vaccine safety reports protected. You should consider using advanced reporting software that will control how the information is shared and who has access to it. Windward comes in handy as a reporting tool that can help at every stage of vaccine research and enable controlled sharing and collaboration of reports among peers in the field.
At a time when the world is facing a crippling pandemic like this one, it’s vital to work together to find the fastest way to end the spread of the Coronavirus. Science and Technology can make a huge difference, no wonder vaccine researchers are already using AI and reporting automation software like Windward to speed up the process.
As of March 31st, there were already six promising Coronavirus vaccine trials. Many researchers would be interested in following the progress of these trials without having to wait for them to be published in medical journals. For the sake of saving the globe from further devastation, it would be wise to enable sharing and collaboration of vaccine research reports and clinical trial reports in real-time.
Windward reporting software can address this issue quickly as even an individual researcher can create the templates needed to generate the vaccine market reports without the need for any coding. By speeding up this process, vaccine researchers can create reports and share them quickly.
With Windward, you can have well-structured reports with the help of pre-approved templates, so that a particular group has access to certain pages of the report. This ensures that patented information remains public while key information that could lead to faster approval of a vaccine is made available to other researchers. This can also help to have the vaccine available on different continents as soon as all the trials are complete.
Even though we need to face the reality that a vaccine will take months before it will be rolled out for mass immunization, we can still look to technology to provide more flexible ways of getting the research to the final stage.
Windward is the silver bullet when it comes to fast and accurate reporting and scientists can integrate it into their systems for swift and secure collaboration in the rush to find the vaccine.